Jushi (OTCMKTS:JUSHF) Trading Up 1.9% - Time to Buy?

Key Points

• Jushi Holdings Inc. shares rose 1.9% during mid-day trading, with a trading price at $0.85.
• The company reported quarterly earnings of ($0.06) earnings per share and revenue of $65.05 million, slightly exceeding analyst estimates.
• Jushi operates as a vertically integrated cannabis company, providing a range of products including flower, extracts, edibles, and vaporization devices under various brand names.

Jushi Holdings Inc. (OTCMKTS:JUSHF - Get Free Report)'s share price was up 1.9% during mid-day trading on Thursday . The company traded as high as $0.85 and last traded at $0.85. Approximately 268,370 shares traded hands during trading, a decline of 12% from the average daily volume of 303,886 shares. The stock had previously closed at $0.83.

Jushi Stock Performance

The business's 50 day simple moving average is $0.70 and its 200-day simple moving average is $0.46. The stock has a market capitalization of $167.00 million, a price-to-earnings ratio of -2.93 and a beta of -0.99.

Jushi (OTCMKTS:JUSHF - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.06). The firm had revenue of $65.05 million for the quarter, compared to analyst estimates of $64.67 million. As a group, sell-side analysts expect that Jushi Holdings Inc. will post -0.23 EPS for the current year.

About Jushi

Jushi Holdings Inc, a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.